Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profiling
Ewan Hunter, Alexandre Akoulitchev, Benedict Egan, William B. Messer(Oregon Health & Science University), Zoë L. Lyski(Oregon Health & Science University), Dmitri Pchejetski(University of East Anglia), Aroul Ramadass, Adam J. Wilson, Jane Mellor(University of Oxford), Paulina Brajer, Christina Koutsothanasi, Amanda E. Brunton(COPD Foundation), Jurjen W. Westra(Scripps Research Institute), Thomas Lavin, Ann Dring, Ryan Powell, Peter A. Robbins(University of Oxford), Catriona Williams, Rama Vancheeswaran(Oxford University Hospitals NHS Trust), Francisco C. Santos, Aemilia Katzinski, Matthew Parnall, Andrew Barlow(West Hertfordshire Hospitals NHS Trust), Matthew Salter
Cited by 4
Related Papers
Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders
|Proceedings of the National Academy of Sciences|2010|854
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174